Target Name: CCR9
NCBI ID: G10803
Review Report on CCR9 Target / Biomarker Content of Review Report on CCR9 Target / Biomarker
CCR9
Other Name(s): C-C motif chemokine receptor 9 | CCR9_HUMAN | C-C chemokine receptor type 9 | G protein-coupled receptor 28 | G-protein coupled receptor 28 | chemokine (C-C motif) receptor 9 | CCR-9 | CC-CKR-9 | Chemokine CCR9 receptor | CDw199 | GPR-9-6 | C-C CKR-9 | GPR28 | CCR9 variant A | C-C chemokine receptor type 9 (isoform A) | C-C motif chemokine receptor 9, transcript variant A

CCR9: A Protein Involved in T-cell Regulation and Inflammation

CCR9 (C-C motif chemokine receptor 9) is a protein that is expressed in various tissues throughout the body, including the immune system, and is involved in the regulation of cellular signaling pathways. It is a member of the chemokine receptor family, which includes proteins that are involved in the regulation of cell surface signaling processes, including the regulation of T-cell proliferation and the regulation of inflammation.

CCR9 is a protein that is expressed in various tissues throughout the body, including the immune system, and is involved in the regulation of cellular signaling pathways. It is a member of the chemokine receptor family, which includes proteins that are involved in the regulation of cell surface signaling processes, including the regulation of T-cell proliferation and the regulation of inflammation.

One of the key functions of CCR9 is its role in the regulation of T-cell proliferation. T-cells are a type of immune cell that play a critical role in the regulation of immune responses, and they are involved in the regulation of many different cellular signaling pathways. CCR9 is involved in the regulation of T-cell proliferation by signaling pathways that involve the activation and proliferation of T-cells, as well as the regulation of their differentiation and death.

CCR9 is also involved in the regulation of inflammation. Inflammation is a critical immune response that helps the body to defend itself against harmful substances, such as pathogens and damaged tissue. CCR9 is involved in the regulation of inflammation by signaling pathways that involve the activation and regulation of immune cells, including T-cells.

In addition to its role in T-cell regulation, CCR9 is also involved in the regulation of cellular signaling pathways that are important for many different cellular processes. For example, CCR9 is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. It is also involved in the regulation of cell migration, which is the process by which cells move from one location to another in the body.

CCR9 is a protein that is involved in many different cellular signaling pathways, and it is a potential drug target or biomarker for a variety of diseases. For example, CCR9 has been shown to be involved in the regulation of T-cell proliferation and differentiation, which makes it an attractive target for drugs that are designed to modulate these processes. Additionally, CCR9 has been shown to be involved in the regulation of inflammation, which makes it an attractive target for drugs that are designed to modulate the immune response.

In conclusion, CCR9 is a protein that is involved in the regulation of cellular signaling pathways that are important for many different cellular processes. It is a potential drug target or biomarker for a variety of diseases, including T-cell proliferation and differentiation, as well as inflammation. Further research is needed to fully understand the role of CCR9 in cellular signaling pathways and to develop effective treatments for diseases that are caused by the disruption of these processes.

Protein Name: C-C Motif Chemokine Receptor 9

Functions: Receptor for chemokine SCYA25/TECK. Subsequently transduces a signal by increasing the intracellular calcium ions level

The "CCR9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCR9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCRL2 | CCS | CCSAP | CCSER1 | CCSER2 | CCT2 | CCT3 | CCT4 | CCT5 | CCT6A | CCT6B | CCT6P1 | CCT6P3 | CCT7 | CCT8 | CCT8L1P | CCT8L2 | CCT8P1 | CCZ1 | CCZ1B | CCZ1P-OR7E38P | CD101 | CD101-AS1 | CD109 | CD14 | CD151 | CD160 | CD163 | CD163L1 | CD164 | CD164L2 | CD177 | CD177P1 | CD180 | CD19 | CD1A | CD1B | CD1C | CD1D | CD1E | CD2 | CD200 | CD200R1 | CD200R1L | CD207 | CD209 | CD22 | CD226 | CD24 | CD244 | CD247 | CD248 | CD24P2 | CD27 | CD27-AS1 | CD274 | CD276 | CD28 | CD2AP | CD2BP2 | CD3 Complex (T Cell Receptor Complex) | CD300A | CD300C | CD300E | CD300LB | CD300LD | CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70